Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210)
2017
2 citations
Journal Article
Field-Weighted Citation Impact:
0.11
·
UCLA Health
Maria Mancini
·
Catabasis Pharmaceuticals (United States)
Pradeep Bista
·
Catabasis Pharmaceuticals (United States)
Andrew J. Nichols
·
Catabasis Pharmaceuticals (United States)
Richard S. Finkel
·
Nemours Children's Clinic
Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210) | Researchclopedia